Collection of biological parameters
PreclinicalBiologic
Collection of biological parameters is one of 45 biologic programs targeting Eating Disorder. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
55 competitors in Eating Disorder
#DrugCompanyPhaseTrials
1Namenda
AbbVieApproved
Cymbalta
Alnylam PharmaceuticalsApproved
Atarax
PfizerApproved
Victoza
Novo NordiskApproved
Sunosi
AAxsome Therapeutics, Inc.
Approved
Strattera
MMap77
Approved
Zyprexa
MMODAG GmbH
Approved
E-Mycin
AAzurity Pharmaceuticals
Approved
Zonegran
AAzurity Pharmaceuticals
Approved
Vyvanse
TakedaPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- IIstituto Auxologico Italiano